RPS6KB1 and colorectal carcinoma: Therefore, one key finding of the study is that IMT1 treatment or POLRMT silencing in primary CRC cells significantly decreased the phosphorylation of Akt1-S6K, whereas POLRMT overexpression had the opposite effect.